COG New England 2024 - CEO Perspectives on Funding Clinical Stage Biotechs
CEO Perspectives on Funding Clinical Stage Biotechs Produced in partnership with Zymewire, authored by Alec de la Durantaye, Product...
top of page
Our Blog
Search
David Jones
1 min
COG New England 2024 - Strategic Contracting for Clinical Trial Dominance
Strategic Contracting for Clinical Trial Dominance In her presentation at the recent COG New England meeting, Lynn Agata, the Director of...
David Jones
2 min
COG New England 2024 - Is Clinical Supply the Weakest Link in Your Chain?
"Is Clinical Supply the Weakest Link in Your Chain?" by Benedict Hirth, MYONEX In his presentation at the recent COG New England meeting,...
David Jones
2 min
COG New England 2024 - Planning for Phase 1 Success
Planning for Phase 1 Success: Key Takeaways, Deb Kientop, Deka Biosciences Deb Kientop, VP of Clinical Operations at Deka Biosciences,...
bottom of page